IndraLab

Statements


USP14 inhibits MAPT. 6 / 6
| 6

reach
"The DUB USP14 suppresses turnover of Tau and TDP-43 in mouse embryonic fibroblasts (MEFs) by impairing the protea-some; therefore, small-molecule inhibitors of USP14 could help clear these toxic proteins from cells."

reach
"Previous in vitro studies indicated that either loss of USP14 or inhibition of USP14’s catalytic activity increased the degradation of both model proteasome substrates and over-expressed TARDBP, PRNP, and MAPT proteins in cultured cells (Hanna et al., 2006; Homma et al., 2015; Lee et al., 2010; Lee et al., 2011)."

reach
"A variant of IU1, called IU1-47, which was 10-fold more potent in inhibiting USP14’s ubiquitin hydrolase activity, also enhanced degradation of MAPT in primary cortical neurons (Boselli et al., 2017)."

reach
"Moreover, IU1-47, a small molecule inhibitor of USP14, was also shown to accelerate the degradation of tau protein (Table 2) (Boselli et al., 2017)."

reach
"USP14 aptamers enhanced tau degradation in cultured cells and protected against oxidative stress."

reach
"In conclusion, pharmacologically inhibiting (with low or high IU1 concentrations) or genetically down-regulating USP14 fail to enhance proteasomal degradation of Ub-proteins or Tau in neurons."